Sustaining the ever-evolving global Regulatory space of the life sciences industry is strenuous. Therefore, it is necessary for manufacturers to keep abreast with the latest Regulatory information to ensure compliance across all the business functions, such as clinical development, release, and marketing scrutiny of medicines.
However, considering the dearth of information from various sources, evaluating the right information and analyzing what is required for submissions and further has become a cumbersome task. This is why focusing and concluding the right choices in favour of the manufacturer’s Regulatory strategy within a limited time makes all the difference. And, one of the most fruitful ways of obtaining the information is to opt for Regulatory Intelligence.
Regulatory Intelligence (RI) is a way of administering data and information from several available resources to devise a compliant Regulatory strategy. RI also means micro-scoping the details and segregating the significant outcome of defining consequences, prospects and building the necessary block of business requirements and choices. How can one showcase these details? Through various types of RI reports such as:
- Structured RI Reports: Produced using pre-defined templates. The template (Table of Content) can be decided by the concerned company.
- Regulatory Insights: This report is based on pre-decided topics. The topics can range from labeling, CMC, Regulations, to certain departments. The report is presented with a brief summary (Synopsis), associated literature documents as attachments. These insights can be qualified under many pre-defined categories.
- Regulatory Events Tracking: Global Regulatory live and virtual events that impart Health authority and industry-based intelligence are tracked. It supports Regulatory learning and development.
- Regulatory News Tracking: Relevant global Regulatory News can be tracked and distributed to subscribers.
- Regulatory Guidance Tracking: Health Authorities and other industry directives, guidance, regulations, and recommendations, can be tracked through the lifecycle of guidance from draft state to implementation and withdrawal (if any).
What are the Components of RI?
The components of Regulatory Intelligence are defined by outlining the possibility (e.g., GxP, quality), sponsors, and transmission networks. It requires the knowledge of the company agenda and its products, the sequences, enhancement, and quantification. The major focus of any RI is on the quality of in-house Regulatory intelligence functionalities, which cannot be compromised at any cost since this holds the responsibility of guaranteeing recognition and research to update the life sciences landscape.
Having said that, Regulatory Intelligence is far more than just data mining. Marginally, it might be responsible for a few assessments, shareholder identification, ranking, and trends in the Regulatory world, and estimation. Sometimes Regulatory strategy and reactions from the Health Authorities might also influence the same. Life Sciences enterprises around the world expect robust Regulatory assistance to decide on crucial choices, like intensifying their product portfolio or promoting their products across various geographies. Meanwhile, they face key challenges while deciphering local database requirements, new regulations, component and evaluation, labeling and packaging obligations, import regulations, local GxP requirements, etc. In these circumstances, there is an indisputable requirement to guarantee that firms are informed of these current geo-specific regulations and of any future guidelines to be announced. When this turns out to be vital, companies require reliable Regulatory Intelligence (RI), which can focus on all the challenges correctly.
Hence, companies looking for Regulatory Intelligence are advised to reach out to a Regulatory expert with a global network. Additionally, companies can also look out for a Regulatory Intelligence software that can instantly help them track Regulatory information from various sources in real-time